Breast Cancer Research Foundation
OrganisationROR
Trials
Collaborator, Phase 2, Not yet recruiting, 140 people, 30 Mar 2026
Collaborator, Phase 2, Recruiting, 700 people, 14 Jan 2026
Collaborator, Phase 2, Recruiting, 140 people, 1 May 2025
Collaborator, Phase 2, Terminated, 9 people, 27 Sept 2024
Collaborator, Phase 1/2, Recruiting, 22 people, 16 Jul 2024
Collaborator, Phase 2, Recruiting, 140 people, 15 Apr 2024
Collaborator, Phase 2, Recruiting, 30 people, 7 Feb 2024
Collaborator, Phase 1, Recruiting, 50 people, 23 Jan 2024
Collaborator, Phase 2, Recruiting, 60 people, 21 Dec 2023
Collaborator, Phase 2, Recruiting, 168 people, 6 May 2023
Collaborator, Phase 2, Terminated, 4 people, 22 Nov 2022
Collaborator, Phase 2, Recruiting, 96 people, 12 Apr 2021
Collaborator, Phase 2, Completed, 53 people, 5 Aug 2020
Collaborator, Phase 2, Active, not recruiting, 120 people, 23 Jun 2020
Collaborator, Phase 2, Active, not recruiting, 138 people, 20 Nov 2018
Collaborator, Phase 2, Terminated, 148 people, 28 Apr 2014
Collaborator, Phase 2, Completed, 40 people, 8 Mar 2011
Collaborator, Phase 2, Completed, 35 people, 30 Jun 2009
Collaborator, Phase 2, Status unknown, 100 people, 4 Jun 2009
Collaborator, Phase 2, Completed, 80 people, 23 Dec 2008
Sources: clinicaltrials.gov
Awards made
Immune health and early detection assessment in individuals with BRCA1/2 pathogenic variants, BCRF-26-039, 2026–2028, 1 Oct 2026
Immune health and early detection assessment in individuals with BRCA1/2 pathogenic variants, BCRF-26-039, 450k, 2026–2028, 1 Oct 2026
Dual GLP-1/GIP Receptor Agonism for Mitigation of Aromatase Inhibitor-Induced Toxicities: A Pilot Biomarker Study, BCRF-26-231, 2026–2027, 1 Oct 2026
The University of Texas MD Anderson Cancer Center
Dual GLP-1/GIP Receptor Agonism for Mitigation of Aromatase Inhibitor-Induced Toxicities: A Pilot Biomarker Study, BCRF-26-231, 225k, 2026–2027, 1 Oct 2026
Providing a large, resource rich database to support research on long-term survivorship in postmenopausal women with breast cancer, BCRF-INV-garnet-l-anderson, 2026, 1 Jan 2026
Providing a large, resource rich database to support research on long-term survivorship in postmenopausal women with breast cancer, BCRF-INV-garnet-l-anderson, 2026, 1 Jan 2026
Creating healthcare infrastructure and training health care professionals in Rwanda to ensure that previously underserved women receive quality screening and treatment for breast cancer, BCRF-INV-lydia-pace, 2025, 1 Jan 2025
Creating healthcare infrastructure and training health care professionals in Rwanda to ensure that previously underserved women receive quality screening and treatment for breast cancer, BCRF-INV-lydia-pace, 2025, 1 Jan 2025
Developing better risk prediction models by identifying and incorporating biomarkers of environmental exposures, BCRF-INV-hui-chen-wu, 2025, 1 Jan 2025
Developing better risk prediction models by identifying and incorporating biomarkers of environmental exposures, BCRF-INV-hui-chen-wu, 2025, 1 Jan 2025
Reducing side effects of breast cancer treatments to improve survivors’ physical health and quality of life, BCRF-INV-mina-sedrak, 2025, 1 Jan 2025
Creating healthcare infrastructure and training health care professionals in Rwanda to ensure that previously underserved women receive quality screening and treatment for breast cancer, BCRF-INV-cyprien-shyirambere, 2020, 1 Jan 2020
Using artificial intelligence to identify young women at elevated risk for breast cancer who would be missed by conventional risk assessment, BCRF-INV-elizabeth-mittendorf, 2019, 1 Jan 2019
Using artificial intelligence to identify young women at elevated risk for breast cancer who would be missed by conventional risk assessment, BCRF-INV-elizabeth-mittendorf, 2019, 1 Jan 2019
Evaluating the use of contrast-enhanced spectral mammography as a breast cancer screening option for women with dense breast tissue, BCRF-INV-christopher-e-comstock, 2019, 1 Jan 2019
Evaluating the use of contrast-enhanced spectral mammography as a breast cancer screening option for women with dense breast tissue, BCRF-INV-christopher-e-comstock, 2019, 1 Jan 2019
Using advanced tools of artificial intelligence to develop methods to improve breast cancer screening and identify women most at risk, BCRF-INV-constance-d-lehman, 2019, 1 Jan 2019
Massachusetts General Hospital
Using advanced tools of artificial intelligence to develop methods to improve breast cancer screening and identify women most at risk, BCRF-INV-constance-d-lehman, 2019, 1 Jan 2019
Sources: openalex.org
Funded papers
p16INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer
10 Sept 2026
Cardiometabolic Health and Risk of Breast Cancer Subtypes Among US Black Women
7 Sept 2026
Sources: api.crossref.org
Named in competing interests
Projected Benefit of Bilateral Salpingo-Oophorectomy by Age in BRCA Carriers
Grants or research support, 23 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov